U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951074) titled 'Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes' on April 04.
Brief Summary: Type 1 Diabetes is a chronic autoimmune disease. It results from autoimmune destruction of pancreatic Beta cells leading to absolute insulin insufficiency. The establishment of pluripotent like human stem cells derived from adipose tissue derived mesenchymal cell origin have introduced a new potential source for cell therapy in type 1 diabetic patients, especially in light of recent successes in producing glucose-sensitive insulin secreting cells and this will be the scope of this study. In the last decade, human clinical trials ...